![5-methyl-7-(2-methyl-1H-imidazol-1-yl)-3-phenyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine structure](/static/products/902/902009-75-0.png)
5-methyl-7-(2-methyl-1H-imidazol-1-yl)-3-phenyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine
TL;DR: 5-methyl-7-(2-methyl-1H-imidazol-1-yl)-3-phenyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine (CAS 902009-75-0) is a chemical compound with molecular formula C18H14F3N5 and molecular weight 357.12 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
5-methyl-7-(2-methylimidazol-1-yl)-3-phenyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine
Also Known As: 5-methyl-7-(2-methyl-1H-imidazol-1-yl)-3-phenyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine, 5-methyl-7-(2-methylimidazol-1-yl)-3-phenyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine
| Molecular Formula | C18H14F3N5 |
|---|---|
| Molecular Weight | 357.12 g/mol |
| LogP | 4.21764 |
| Topological Polar Surface Area | 48.01 Ų |
| Hydrogen Bond Donors | 0 |
| Hydrogen Bond Acceptors | 3 |
| Rotatable Bonds | 2 |
| Exact Mass | 357.12012 |
| Heavy Atoms | 26 |
| Complexity | 1093.413 |
Chemical Identifiers
| CAS Number | 902009-75-0 |
|---|---|
| SMILES | CC1=NC2=C(C(=NN2C(=C1)N3C=CN=C3C)C(F)(F)F)C4=CC=CC=C4 |
Product Overview
5-methyl-7-(2-methyl-1H-imidazol-1-yl)-3-phenyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine (CAS 902009-75-0), with molecular formula C18H14F3N5 and molecular weight 357.12 g/mol. IUPAC: 5-methyl-7-(2-methylimidazol-1-yl)-3-phenyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine.
Chemical Property Profile of 5-methyl-7-(2-methyl-1H-imidazol-1-yl)-3-phenyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine
Property Insights of 5-methyl-7-(2-methyl-1H-imidazol-1-yl)-3-phenyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine
The XLogP value of 4.21764 indicates that 5-methyl-7-(2-methyl-1H-imidazol-1-yl)-3-phenyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. With a topological polar surface area (TPSA) of 48.01 Ų, 5-methyl-7-(2-methyl-1H-imidazol-1-yl)-3-phenyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine exhibits relatively low polarity, potentially indicating favorable cell membrane permeability. Following Lipinski's Rule of Five, 5-methyl-7-(2-methyl-1H-imidazol-1-yl)-3-phenyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine has 0 hydrogen bond donor(s) and 3 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 5-methyl-7-(2-methyl-1H-imidazol-1-yl)-3-phenyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine?
The CAS number of 5-methyl-7-(2-methyl-1H-imidazol-1-yl)-3-phenyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine is 902009-75-0.
What is the molecular formula of 5-methyl-7-(2-methyl-1H-imidazol-1-yl)-3-phenyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine?
The molecular formula of 5-methyl-7-(2-methyl-1H-imidazol-1-yl)-3-phenyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine is C18H14F3N5.
What is the molecular weight of 5-methyl-7-(2-methyl-1H-imidazol-1-yl)-3-phenyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine?
The molecular weight of 5-methyl-7-(2-methyl-1H-imidazol-1-yl)-3-phenyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine is 357.12 g/mol.
Where can I buy 5-methyl-7-(2-methyl-1H-imidazol-1-yl)-3-phenyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine?
You can request a quote for 5-methyl-7-(2-methyl-1H-imidazol-1-yl)-3-phenyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 5-methyl-7-(2-methyl-1H-imidazol-1-yl)-3-phenyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine?
Yes, KEHONG BIO provides custom synthesis services for 5-methyl-7-(2-methyl-1H-imidazol-1-yl)-3-phenyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.